Manganese-Induced Parkinsonism due to Ephedrone Abuse

Joint Authors

Sikk, Katrin
Haldre, Sulev
Taba, Pille
Aquilonius, Sten-Magnus

Source

Parkinson’s Disease

Issue

Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-8, 8 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2011-01-18

Country of Publication

Egypt

No. of Pages

8

Main Subjects

Diseases
Medicine

Abstract EN

During recent years, a syndrome of hypokinesia, dysarthria, dystonia, and postural impairment, related to intravenous use of a “designer” psychostimulant derived from pseudoephedrine using potassium permanganate as the oxidant, has been observed in drug addicts in several countries in Eastern Europe with some cases also in Western countries.

A levodopa unresponsive Parkinsonian syndrome occurs within a few months of abusing the homemade drug mixture containing ephedrone (methcathinone) and manganese.

The development of this neurological syndrome has been attributed to toxic effects of manganese, but the role of the psychostimulant ephedrone is unclear.

This paper describes the clinical syndrome, results of neuroimaging, and therapeutic attempts.

American Psychological Association (APA)

Sikk, Katrin& Haldre, Sulev& Aquilonius, Sten-Magnus& Taba, Pille. 2011. Manganese-Induced Parkinsonism due to Ephedrone Abuse. Parkinson’s Disease،Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-991118

Modern Language Association (MLA)

Sikk, Katrin…[et al.]. Manganese-Induced Parkinsonism due to Ephedrone Abuse. Parkinson’s Disease No. 2011 (2011), pp.1-8.
https://search.emarefa.net/detail/BIM-991118

American Medical Association (AMA)

Sikk, Katrin& Haldre, Sulev& Aquilonius, Sten-Magnus& Taba, Pille. Manganese-Induced Parkinsonism due to Ephedrone Abuse. Parkinson’s Disease. 2011. Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-991118

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-991118